Search research articles
Contact Us
Filters
Showing results (1-10 of 220) with videos related to
Page
of 22
Sort By:
The Journal of Urology
|
November 1, 1995
Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced bladder cancer overview collaboration
H I Scher
The Journal of Urology
|
November 1, 1992
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study
H I Scher
The Urologic Clinics of North America
|
November 1, 1992
Systemic chemotherapy in regionally advanced bladder cancer. Theoretical considerations and results
H I Scher
Journal of the National Cancer Institute
|
December 7, 2000
HER2 in prostate cancer--a viable target or innocent bystander?
H I Scher
The Journal of Urology
|
August 1, 1994
High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder
H I Scher
The Journal of Urology
|
February 1, 1995
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5 year follow-up
H I Scher
The Journal of Urology
|
May 1, 1994
Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis
H I Scher
Progress in Clinical and Biological Research
|
January 1, 1990
Chemotherapy for invasive bladder tumors
H I Scher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1989
Should single agents be standard therapy for urothelial tract tumors?
H I Scher
Current Opinion in Oncology
|
June 1, 1992
Prostatic cancer: are we closer to rational treatment selection?
H I Scher
Page
of 22
Search research articles
Search
Showing results (1-10 of 220) with videos related to
Sort By:
Page
of 22
The Journal of Urology
|
November 1, 1995
Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced bladder cancer overview collaboration
H I Scher
The Journal of Urology
|
November 1, 1992
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study
H I Scher
The Urologic Clinics of North America
|
November 1, 1992
Systemic chemotherapy in regionally advanced bladder cancer. Theoretical considerations and results
H I Scher
Journal of the National Cancer Institute
|
December 7, 2000
HER2 in prostate cancer--a viable target or innocent bystander?
H I Scher
The Journal of Urology
|
August 1, 1994
High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder
H I Scher
The Journal of Urology
|
February 1, 1995
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5 year follow-up
H I Scher
The Journal of Urology
|
May 1, 1994
Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis
H I Scher
Progress in Clinical and Biological Research
|
January 1, 1990
Chemotherapy for invasive bladder tumors
H I Scher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1989
Should single agents be standard therapy for urothelial tract tumors?
H I Scher
Current Opinion in Oncology
|
June 1, 1992
Prostatic cancer: are we closer to rational treatment selection?
H I Scher
Page
of 22